Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Motavizumab for Outpatient Treatment of Children With RSV Illness
NCT00435227Phase 2Terminated
- Sponsor
- MedImmune
- Start
- Mar 2007
- Primary completion
- May 2008
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of motavizumab in respiratory syncytial virus infection (RSV), sponsored by MedImmune. Started Mar 2007; status: terminated.
02
Drugs
motavizumab
03
Conditions
respiratory syncytial virus infection (RSV)
Beyond the preview
Go deeper on NCT00435227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00435227.